ArticleCancer & metabolism2021

A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism.

Pratik Shriwas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.